SEC Form 4 · accession 0001209191-15-039437
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2015 | M | 1,125 | $37.86 | A | 19,500 | D | |
| Common StockF2,F3 | May 4, 2015 | S | 577 | $126.15 | D | 18,923 | D | |
| Common StockF3,F4 | May 4, 2015 | S | 332 | $127.09 | D | 18,591 | D | |
| Common StockF3,F5 | May 4, 2015 | S | 216 | $128.22 | D | 18,375 | D | |
| Common Stock | May 5, 2015 | M | 1,687 | $45.11 | A | 20,062 | D | |
| Common Stock | May 5, 2015 | M | 1,289 | $77.31 | A | 21,351 | D | |
| Common StockF3,F6 | May 5, 2015 | S | 1,676 | $121.92 | D | 19,675 | D | |
| Common StockF3,F7 | May 5, 2015 | S | 1,000 | $122.90 | D | 18,675 | D | |
| Common StockF3,F8 | May 5, 2015 | S | 200 | $123.85 | D | 18,475 | D | |
| Common Stock | May 5, 2015 | S | 100 | $125.20 | D | 18,375 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F9 | $37.86 | May 4, 2015 | M | 1,125 | D | — | Feb 1, 2022 | Common Stock | 1,125 | 3,375 | D |
| Stock Option (right to buy)F10 | $45.11 | May 5, 2015 | M | 1,687 | D | — | Feb 4, 2023 | Common Stock | 1,687 | 11,813 | D |
| Stock Option (right to buy)F11 | $77.31 | May 5, 2015 | M | 1,289 | D | — | Feb 4, 2024 | Common Stock | 1,289 | 14,179 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F10The option vests in 16 quarterly installments from 02/05/2013.
- F11The option vests in 16 quarterly installments from 02/05/2014.
- F2Open market sales reported on this line occurred at a weighted average price of $126.15 (range $125.64 to $126.63).
- F3Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $127.09 (range $126.87 to $127.40).
- F5Open market sales reported on this line occurred at a weighted average price of $128.22 (range $127.99 to $128.68).
- F6Open market sales reported on this line occurred at a weighted average price of $121.92 (range $121.56 to $122.41).
- F7Open market sales reported on this line occurred at a weighted average price of $122.90 (range $122.58 to $123.33).
- F8Open market sales reported on this line occurred at a weighted average price of $123.85 (range $123.68 to $124.01).
- F9The option vests in 16 quarterly installments from 02/02/2012.